sRANKL/osteoprotegerin complex and biochemical markers in a cohort of male and female hemodialysis patients (Q51728628)

10 April 2018

title

sRANKL/osteoprotegerin complex and biochemical markers in a cohort of male and female hemodialysis patients (English)

1 reference

10 April 2018

author name string

K K Doumouchtsis

1

1 reference

10 April 2018

A I Kostakis

2

1 reference

10 April 2018

S K Doumouchtsis

3

1 reference

10 April 2018

M P Tziamalis

4

1 reference

10 April 2018

C Tsigris

5

1 reference

10 April 2018

M A Kostaki

6

1 reference

10 April 2018

D N Perrea

7

1 reference

10 April 2018

publication date

1 October 2007

1 reference

10 April 2018

Journal of Endocrinological Investigation

published in

1 reference

10 April 2018

volume

30

1 reference

10 April 2018

issue

9

1 reference

10 April 2018

page(s)

762-766

1 reference

10 April 2018

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03350814

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350814

Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350814

TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350814

The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350814

Modulation of osteoclast formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350814

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350814

Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350814

The role of cytokines in skeletal remodelling: possible consequences for renal osteodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350814

Serum osteoprotegerin and renal osteodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350814

Correlates of osteoprotegerin levels in women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350814

Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350814

Direct and indirect estrogen actions on osteoblasts and osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350814

Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350814

Osteoprotegerin Reduces the Serum Level of Receptor Activator of NF- B Ligand Derived from Osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350814

Increased serum osteoprotegerin level in older and diabetic hemodialysis patients

21 January 2018

1 reference

12 December 2020

Minireview: the OPG/RANKL/RANK system

1 reference

12 December 2020

Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast

1 reference

12 December 2020

Circulating osteoprotegerin is not removed through haemodialysis membrane

1 reference

12 December 2020

Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status

1 reference

12 December 2020

Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure

1 reference

12 December 2020

[The relationships between changes of serum osteoprotegerin, nuclear factor-kappa B ligand receptor activator, and age, menopause, bone biochemical markers and bone mineral densities in women aged 20 - 75]

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03350814

1 reference

10 April 2018

release_6juxdlolife77ntfbzce2n3una

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6juxdlolife77ntfbzce2n3una

24 November 2022

mapped directly with Wikidata item

1 reference

10 April 2018